Potentials of Probiotics as Alternative Therapy in Combating Bacterial Diseases: A Review

References (113)

1. 1 Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation [DOI]
2. 2 The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction [DOI]
3. 3 Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus [DOI]
4. 4 Overview of gut flora and probiotics [DOI]
5. 5 Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome [DOI]
6. 6 Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors [DOI]
7. 7 Mechanisms of probiotic actions – A review [DOI]
8. 8 Probiotic Spectra of Lactic Acid Bacteria (LAB) [DOI]
9. 9 Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR [DOI]
10. 10 A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children.
11. 11 Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial [DOI]
12. 12 Effect of Long–Term Consumption of a Probiotic Bacterium, Lactobacillus rhamnosus GG, in Milk on Dental Caries and Caries Risk in Children [DOI]
13. 13 Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children [DOI]
14. 14 Probiotic and other functional microbes: from markets to mechanisms [DOI]
15. 15 Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice [DOI]
16. 16 Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic [DOI]
17. 17 Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study [DOI]
18. 18 Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants [DOI]
19. 19 Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis [DOI]
20. 20 Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota [DOI]
21. 21 Probiotics promote gut health through stimulation of epithelial innate immunity [DOI]
22. 22 Lactobacilli and Streptococci Induce Interleukin-12 (IL-12), IL-18, and Gamma Interferon Production in Human Peripheral Blood Mononuclear Cells [DOI]
23. 23 Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model [DOI]
24. 24 Efficacy ofLactobacillus GGas a Diarrheal Preventive in Travelers [DOI]
25. 25 Modulating immune responses with probiotic bacteria [DOI]
26. 26 Ingestion of Yogurt Containing Lactobacillus acidophilus as Prophylaxis for Candidal Vaginitis [DOI]
27. 27 Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB [DOI]
28. 28 Probiotics: what are they? What are their effects on gut physiology? [DOI]
29. 29 Probiotics: their role in the treatment and prevention of disease [DOI]
30. 30 Antiallergic Effects of Probiotics1, [DOI]
31. 31 Isolation ofChlamydia pneumoniaefrom a Carotid Endarterectomy Specimen [DOI]
32. 32 A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates [DOI]
33. 33 Systemic Immunity-Enhancing Effects in Healthy Subjects Following Dietary Consumption of the Lactic Acid BacteriumLactobacillus rhamnosusHN001 [DOI]
34. 34 Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man [DOI]
35. 35 Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative? [DOI]
36. 36 Probiotic bacteria: myth or reality? [DOI]
37. 37 Lactobacilli and Streptococci Activate NF-κB and STAT Signaling Pathways in Human Macrophages [DOI]
38. 38 Probiotics and Inflammatory Bowel Disease: Is There a Scientific Rationale? [DOI]
39. 39 Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: An in vivo study in lactase-deficient humans [DOI]
40. 40 Treatment Strategies for Small Bowel Bacterial Overgrowth in Short Bowel Syndrome [DOI]
41. 41 Lactobacillus Strains and Vaginal Ecology [DOI]
42. 42 Microbial colonization influences composition and T‐cell receptor Vβ repertoire of intraepithelial lymphocytes in rat intestine [DOI]
43. 43 Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model [DOI]
44. 44 Effects of Bifidobacterium infantis 35624 on Post-Inflammatory Visceral Hypersensitivity in the Rat [DOI]
45. 45 Original Research: A Patented Strain ofBacillus coagulansIncreased Immune Response to Viral Challenge [DOI]
46. 46 LiveLactobacillus rhamnosusandStreptococcus pyogenesdifferentially regulate Toll-like receptor (TLR) gene expression in human primary macrophages [DOI]
47. 47 ESTERASE ACTIVITY IN LEUKOCYTES DEMONSTRATED BY THE USE OF NAPHTHOL AS-D CHLOROACETATE SUBSTRATE [DOI]
48. 48 Probiotics for ulcerative colitis therapy Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomized trial. Lancet 1999;354:635–9. [DOI]
49. 49 Lactobacillus paracaseiReduces Intestinal Inflammation in Adoptive Transfer Mouse Model of Experimental Colitis [DOI]
50. 50 Metchnikoff and the centenary of probiotics: an update of their use in gastroenteric pathology during the age of development.
51. 51 Resistance ofBacillusEndospores to Extreme Terrestrial and Extraterrestrial Environments [DOI]
52. 52 Probiotics, prebiotics, and synbiotics—approaching a definition [DOI]
53. 53 Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial [DOI]
54. 54 Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles [DOI]
55. 55 Probiotics and their fermented food products are beneficial for health [DOI]
56. 56 Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics [DOI]
57. 57 Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis [DOI]
58. 58 Effects of Gut Microbes on Nutrient Absorption and Energy Regulation [DOI]
59. 59 Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression [DOI]
60. 60 Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index [DOI]
61. 61 Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice [DOI]
62. 62 Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease [DOI]
63. 63 Enhancement of the Circulating Antibody Secreting Cell Response in Human Diarrhea by a Human Lactobacillus Strain [DOI]
64. 64 The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases [DOI]
65. 65 Lactobacillus GG Administered in Oral Rehydration Solution to Children with Acute Diarrhea: A Multicenter European Trial [DOI]
66. 66 Probiotics: Definition, Sources, Selection, and Uses [DOI]
67. 67 Protection from gastrointestinal diseases with the use of probiotics [DOI]
68. 68 Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis [DOI]
69. 69 SUCCESSFUL TREATMENT OF RELAPSING CLOSTRIDIUM DIFFICILE COLITIS WITH LACTOBACILLUS GG [DOI]
70. 70 Health and nutritional benefits from lactic acid bacteria [DOI]
71. 71 Oral probiotics can resolve urogenital infections [DOI]
72. 72 Crohn's Disease and Escherichia coli [DOI]
73. 73 Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria [DOI]
74. 74 A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating [DOI]
75. 75 In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli [DOI]
76. 76 Enhancement of natural and acquired immunity byLactobacillus rhamnosus(HN001),Lactobacillus acidophilus(HN017) andBifidobacterium lactis(HN019) [DOI]
77. 77 Selection of Probiotic Strains for Human Applications [DOI]
78. 78 Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) [DOI]
79. 79 Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. [DOI]
80. 80 Oral Bacterial Therapy Reduces the Duration of Symptoms and of Viral Excretion in Children with Mild Diarrhea [DOI]
81. 81 Differences in Bifidobacterium flora composition in allergic and healthy infants [DOI]
82. 82 The Impact of Probiotic on Gut Health [DOI]
83. 83 The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat [DOI]
84. 84 Development and Maintenance of the Gut‐Associated Lymphoid Tissue (Galt): the Roles of Enteric Bacteriaand Viruses [DOI]
85. 85 Prebiotics and Probiotics [DOI]
86. 86 In vitro selection of probiotic lactobacilli: a critical appraisal.
87. 87 Treatment of Recurrent Clostridium difficile Colitis With Lactobacillus GG [DOI]
88. 88 Study of the Possible Mechanisms Involved in the Mucosal Immune System Activation by Lactic Acid Bacteria [DOI]
89. 89 Selection ofLactobacillusStrains for Urogenital Probiotic Applications [DOI]
90. 90 Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis [DOI]
91. 91 Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human [DOI]
92. 92 Antibody repertoire development in fetal and newborn piglets, III. Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues [DOI]
93. 93 Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications [DOI]
94. 94 Probiotics in health maintenance and disease prevention.
95. 95 In vitro adhesion of propionic acid bacteria to human intestinal mucus [DOI]
96. 96 Long-term follow-up after ileoanal pouch procedure [DOI]
97. 97 Colonic food: pre- and probiotics [DOI]
98. 98 Lactobacillus acidophilus and Yogurt in the Prevention and Therapy of Bacterial Vaginosis [DOI]
99. 99 Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine [DOI]
100. 100 VSL3 probiotic mixture induces remission in patients with active ulcerative colitis [DOI]
101. 101 Diversity of the Human Intestinal Microbial Flora [DOI]
102. 102 Probiotics in man and animals [DOI]
103. 103 Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis [DOI]
104. 104 Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice [DOI]
105. 105 Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction [DOI]
106. 106 Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG [DOI]
107. 107 Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome [DOI]
108. 108 Microbial community and metabolomic comparison of irritable bowel syndrome faeces [DOI]
109. 109 Health effects of probiotics and prebiotics A literature review on human studies [DOI]
110. 110 Role of Nutrients and Bacterial Colonization in the Development of Intestinal Host Defense [DOI]
111. 111 Protective Effect ofLactobacillus caseiStrain Shirota on Shiga Toxin-ProducingEscherichia coliO157:H7 Infection in Infant Rabbits [DOI]
112. 112 Functional Taxonomy of Bacterial Hyperstructures [DOI]
113. 113 Gut microbiota and GI health and disease.

Cited by 1

Related research

• Obesity: Multiple Biological Factors — shares topic coverage
• Drug Interactions, Safety and Efficacy of Probiotics — shares topic coverage
• Intestinal Dysbiosis in Systemic Inflamation and Possibilities of Its Correction with Probiotics — shares topic coverage
• P. pentosaceus Administration Attenuates the Severity of Dextran Sulfate Sodium-Induced Colitis and Improve the Intestinal Permeability — shares topic coverage
• Enhancement of Growth and Bioactivities of Probiotic Bacterium Streptococcus thermophilus as Influenced by Lactalbumin Hydrolysate and Inulin Supplementation in Skimmed Milk Medium — shares topic coverage